Skip to Content

Abbott Laboratories/TheraSense

M/04/006

Completed

Transaction details

Proposal whereby Abbott Laboratories (“Abbott”) would acquire all the issued shares of TheraSense, Inc.

Case details

Notification date:26 January 2004
Publication date:26 January 2004
Economic sector:Manufacturing - C
Economic sub-sector:Manufacture of electronics - C.26
Outcome:Cleared

Documents

M.04.006 DeterminationPDF | 154 KB

Timetable

Phase One

Monday, 26 January, 2004 Notification received
Friday, 6 February, 2004 Third party submission deadline
Thursday, 26 February, 2004 Determination issued

Parties Involved

Abbott Laboratories

Manufacture and sale of health care products and services.

TheraSense

TheraSense develops, manufactures and sells glucose monitoring systems designed to reduce the pain of testing for people with diabetes.

Contacts

mergers@ccpc.ie

View all mergers